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Background: Categorizing an inherently continuous predictor in prognostic analyses raises several critical
methodological issues: dependence of the statistical significance on the number and position of the chosen
cut-point(s), loss of statistical power, and faulty interpretation of the results if a non-linear association is incorrectly
assumed to be linear. This also applies to a therapeutic context where investigators of randomized clinical trials
(RCTs) are interested in interactions between treatment assignment and one or more continuous predictors.
Methods/Design: Our goal is to apply the multivariable fractional polynomial interaction (MFPI) approach to
investigate interactions between continuous patient baseline variables and the allocated treatment in an individual
patient data meta-analysis of three RCTs (N = 2,299) from the intensive care field. For each study, MFPI will provide
a continuous treatment effect function. Functions from each of the three studies will be averaged by a novel
meta-analysis approach for functions. We will plot treatment effect functions separately for each study and also
the averaged function. The averaged function with a related confidence interval will provide a suitable basis to assess
whether a continuous patient characteristic modifies the treatment comparison and may be relevant for clinical
decision-making. The compared interventions will be a higher or lower positive end-expiratory pressure (PEEP) ventilation
strategy in patients requiring mechanical ventilation. The continuous baseline variables body mass index, PaO2/FiO2,
respiratory compliance, and oxygenation index will be the investigated potential effect modifiers. Clinical outcomes
for this analysis will be in-hospital mortality, time to death, time to unassisted breathing, and pneumothorax.
Discussion: This project will be the first meta-analysis to combine continuous treatment effect functions derived
by the MFPI procedure separately in each of several RCTs. Such an approach requires individual patient data (IPD).
They are available from an earlier IPD meta-analysis using different methods for analysis. This new analysis strategy
allows assessing whether treatment effects interact with continuous baseline patient characteristics and avoids
categorization-based subgroup analyses. These interaction analyses of the present study will be exploratory in
nature. However, they may help to foster future research using the MFPI approach to improve interaction analyses
of continuous predictors in RCTs and IPD meta-analyses. This study is registered in PROSPERO (CRD42012003129).
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Dichotomizing or categorizing inherently continuous pre-
dictor variables raises several issues for statistical analysis
and interpretation. These issues include dependence of
the statistical significance of the interaction on the num-
ber and position of the chosen cut-points, loss of statistical
power, and a faulty interpretation of the results if a
non-linear association is incorrectly assumed to be linear
[1]. To overcome these issues, Royston and Sauerbrei pro-
posed the so-called multivariable fractional polynomials
interaction (MFPI) approach to investigate potential treat-
ment modifying effects [2,3]. For continuous variables
they propose to estimate a treatment effect function,
which avoids the well-known problems caused by cat-
egorizing continuous variables. To summarize functions
across several studies they suggested a new strategy for
meta-analysis [4].
A recent individual patient data meta-analysis of three
randomized controlled trials (RCTs) showed that the
pre-defined subgroup of patients who suffered from an
acute respiratory distress syndrome (ARDS) had a clinical
benefit across various endpoints if they were treated with
a higher positive end-expiratory pressure (PEEP) ventila-
tion strategy [5,6]. We will use the MFPI approach [2,3]
and the new strategy to summarize functions across RCTs
[4] to re-analyse this dataset of 2,299 critically ill patients
from the previously reported individual patient data (IPD)
meta-analysis [5].
Objectives
The primary aim of the ICEM study is to demonstrate how
methodological issues of interaction/subgroup analyses
of continuous predictors can be handled by combining
a new meta-analysis approach for functions with the
MFPI approach. If IPD are available, MFPI allows in-
vestigating whether a continuous variable interacts with
treatment in one RCT; combination of data from several
RCTs strengthens the assessment concerning a treatment
modifying effect. When comparing two (or more) treat-
ments in an RCT, several continuous variables (for
example, age) are suitable candidates to be investigated
as potential modifiers of the treatment effect. The ICEM
study will be the first example which combines estimation
of treatment effect functions by using MFPI separately
in each of several RCTs with a new approach for a
meta-analysis of functions. As a secondary aim, we will
re-analysis the available IPD data to investigate whether
one or more continuous variables have an influence on
the comparison of two treatment strategies (higher versus
lower PEEP), which is a clinically relevant issue. This
paper is an extended version of the registered protocol
and shows in an exemplary way how to better use the
information from continuous variables if individual patient
data from several RCTs are available. In similar projects, itshould be obvious how to adapt the relevant steps for a
meta-analysis of treatment effect functions.
Methods/Design




The present interaction analyses will be based on IPD
sets from three RCTs identified by a systematic review
in 2010 [5,7-9] (Table 1, total of 2,299 patients). These
trials investigated the benefits and harms of higher-PEEP
ventilation compared to lower-PEEP ventilation in pa-
tients with acute lung injury including ARDS. Trial
eligibility criteria, literature search strategies, and main
results have previously been reported [5]. Standardization
of variables and consistency checks have already been
performed, thus no more data cleaning will be neces-
sary. Before writing the protocol for the study we have
updated the earlier (January 2010) literature search
(MEDLINE, EMBASE, CENTRAL) and could not identify
additional eligible RCTs. Therefore, the present analysis




We will use the MFPI approach [2] to investigate the po-
tential treatment (higher versus lower PEEP) modifying
effects of each of the continuous variables with respect
to a defined outcome. A ‘pair’ of a potential modifier (for
example, body mass index (BMI)) and an outcome (for
example, in-hospital mortality) will be considered as one
investigation. In total, with four potential modifiers and
three outcomes we will have twelve investigations. There
will be no P-value adjustment for multiple investigations.
All patients will be analyzed in the group to which they
were randomized (intention-to-treat principle). For all
analyses, we will use the software STATA version 13.0
(Station College, TX, USA).
We will use MFPI with FP2 functions as the most com-
plex allowable function and we will test for an interaction
at the 5% level in each trial. FP2 functions are extensions
of conventional quadratic functions that provide con-
siderably enhanced flexibility for more realistic modeling
in real data. Instead of only powers 1 and 2, they utilize
additional combinations of powers of the predictor (see
Figure 1 for the powers that may be selected, adapted
from Royston and Sauerbrei [10]). Having only two power
terms, FP2 functions can exhibit at most one maximum
or minimum. We assume that FP2 functions could be a
suitable functional form, assuming that patients with
extremely high or low values of the continuous predictor
Table 1 Characteristics of ALVEOLI, LOVS, and ExPress studies
ALVEOLI (2004) LOVS (2008) ExPress (2008)
Inclusion criteria Diagnosis of acute lung injurya with PaO2/FIO2 ≤ 300 Diagnosis of acute lung injury
a and PaO2/FIO2≤ 250 Diagnosis of acute lung injury
a with PaO2/
FIO2 ≤ 300
Recruitment period 1999 to 2002 2000 to 2006 2002 to 2005
Number of recruiting
hospitals, countries
23, United States 30, Canada, Australia, Saudi Arabia 37, France
Patients randomized to
higher versus lower PEEP
276 versus 273 476 versus 509b 385 versus 383c
Validity:
Concealed allocation Yes Yes Yes
Follow-up for hospital
mortality until day 60
100% 100% 100%
Blinded outcome assessors and data
analysts
Yes Yes Yes
Early stopping Stopped for perceived futility No Stopped for perceived futility
Experimental intervention Higher PEEP according to FiO2 chart, recruitment
maneuvers for first 80 patients
Higher PEEP according to FiO2 chart, required plateau
pressures≤ 40 cmH2O, recruitment maneuvers
PEEP as high as possible without increasing
the maximum inspiratory plateau pressure > 28
to 30 cmH2O
Control intervention Conventional PEEP according to FiO2 chart, required
plateau pressures≤ 30 cmH2O, no recruitment
maneuvers
Conventional PEEP according to FiO2 chart, required
plateau pressures≤ 30 cmH2O, no recruitment maneuvers
Conventional PEEP (between 5 and
9 cmH2O)
to meet oxygenation goals
Ventilator procedures Target tidal volumes of 6 ml/kg of predicted body weight; plateau pressures ≤ 30 cmH2O (with exception as above); respiratory rate≤ 35 breaths/minute,
adjusted to achieve arterial pH 7.30 to 7.45; ventilator mode: volume-assist control (except higher PEEP group in LOVS required pressure control); oxygenation
goals: PaO2 55 to 80 mmHg and SPO2 88 to 95%; standardized weaning)
Abbreviations: ALVEOLI Assessment of Low tidal Volume and Elevated end-expiratory pressure to Obviate Lung Injury, LOVS Lung Open Ventilation Study, ExPress Expiratory Pressure study, PaO2 partial pressure of
arterial oxygen, FiO2 fraction of inspired oxygen, PEEP positive end-expiratory pressure, SPO2 oxygen saturation as measured by pulse oximetry.
aAccording to the American-European Consensus Conference [Bernard GR et al., American journal of respiratory and critical care medicine. 1994 Mar;149(3 Pt 1):818-24. PubMed PMID: 7509706].
bIncludes two patients for whom consent was withdrawn prior to protocol initiation, without patient, family, and caregivers being aware of group assignment (which is 983 patients included in the analysis).



















Figure 1 The variety of curve shapes available with the FP1
family of transformations of a continuous predictor, x. FP1
transformations are simply powers of the form xp. For example,
xp with power P = −1 is the reciprocal (1/x) of x. These powers are
indicated by the numbers on the diagram. Adapted from Royston
and Sauerbrei [10].
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For each potential effect modifier the functional rela-
tionship between this predictor and the outcome will
be illustrated using treatment effect functions, irrespective
of the P-value from the test for interaction. The functional
form derived with the MFPI procedure will be checked for
potential mismodeling by considering the treatment effect
in four subgroups of the predictor of about equal sample
size [11]. The analysis strategy needs re-consideration if
the estimated treatment effect function disagrees severely
with the corresponding results in subgroups, indicating
mismodeling of the treatment effect function. For binary
outcomes, we will estimate odds ratios with 95% confi-
dence intervals (CIs) to quantify the magnitude of effect.
Briel et al. had primarily calculated clinically more intui-
tive relative risks using log-binomial regression instead of
odds ratios, but were confronted with computational
problems of non-converging log-binomial models in some
analyses. For all binary outcomes, they additionally calcu-
lated odds ratios and found similar results although event
rates for hospital mortality were > 30% in treatment and
control groups [6]. Given the similarity of the results we
decided to use the logistic regression model in the present
study in order to prevent computational issues when ap-
plying the MFPI approach. For survival analysis, Kaplan-
Meier estimates and hazard ratios with 95% CIs will be
presented. Of note, all investigations of a survival outcome
will start with a check of the proportional hazards as-
sumption of the effect of treatment in a univariate Cox-
model. We will use the Grambsch-Therneau test for this
purpose. If the proportional hazards assumption is seriously
violated, we will stop the corresponding investigation and
will re-consider a suitable strategy for analysis.Individual patient data meta-analysis
Separately for each study we will conduct an MFPI
analysis to estimate a treatment effect function. For each
modifier-outcome pair, we will use weighted averaging
to obtain a summary treatment effect function based on
all three studies as previously outlined [4]. We will use a
fixed effects approach, because we consider three studies
to be too few for a random effect model although a ran-
dom distribution can be assumed. Usually this averaged
treatment effect function is no FP function. It will be plot-
ted to allow for a qualitative assessment of the possible
interaction based on the full information of a potential
modifier. The individual functions and the averaged func-
tion will be the main results to assess whether the variable
is a treatment modifier for the specific outcome. We will
not conduct any statistical test for the averaged treatment
effect function. Combining P-values from the individual
studies would be one possible way to obtain an overall
P-value but this is probably not very helpful. More suitable
ways to derive an overall P-value need to be investigated.
Potential clustering of data
We realized that the data of the three independent trials
are clustered by recruiting hospitals. Although there is
evidence of considerable ‘center effects’ with data from
intensive care patients, Briel et al. found that the vari-
ance among the 90 recruiting hospitals explained very
little (0.3%) of the total variance for hospital mortality
[6]. Differences in patient baseline characteristics such
as age, probability of death in hospital from prognostic
scores, and proportion of patients with severe sepsis
largely (co-variables in the primary analyses of the present
study) explained the between-hospital variance of 2.6%
found with a basic hierarchical model including only PEEP
group and a categorical trial variable as fixed effects and
recruiting hospitals as a random effect. Given the negli-
gible ‘between-hospital’ variance we decided to forgo any
consideration of ‘center effects’ in the primary analyses of
the present study.
Adjustment for confounders
Because of some imbalances regarding age [7,8] and the
proportion of patients with severe sepsis [8,9], Briel et al.
conducted an adjusted analysis for all outcomes [5].
We will adopt this approach, thus each analysis will be
conducted with adjustment for the following potential
confounders: age (continuous), presence of severe sep-
sis (yes versus no), and predicted probability of dying
in the hospital (based on Acute Physiology and Chronic
Health Evaluation II and Simplified Acute Physiology II
scores, which have similar accuracy [12,13]). Selection of
these potential confounders resulted from a previous
Delphi-like structured survey among experts from the
intensive care field [6]. We will apply the FP1 function
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most complex permitted functional form. Including all
confounders mentioned above, the model will be deter-
mined separately for each of the three outcomes using
MFP (1.0, 0.05), independent of treatment. In the notation
MFP (alpha 1, alpha 2) the value of alpha 1 gives the
significance level for the variable selection part of MFP
and alpha 2 the significance level of the function selection
procedure for continuous variables [10]. Despite some
imbalances in the covariate distributions between PEEP
groups mentioned above, univariate approaches will be
conducted as sensitivity analyses.
Influential points
To circumvent the issue of influential points all continu-
ous variables will be truncated at the 1% and 99%-tile;
meaning that any value below the 1%-tile will be replaced
by the value of the 1%-tile, and any value above the 99%-
tile will be replaced by the value of the 99%-tile. These
truncations will be performed for each study separately.
Handling missing data
Some of the potential modifiers and variables used for
adjustment (see below) have missing values of up to about
10%. In order to use all information in all analyses, we will
impute missing values before the main analysis starts. To
try to ensure that the missing at random assumption is
valid, we will include all outcomes and as many other
variables as possible in the imputation models [14]. Five
imputations will be created using the multiple imputations
by chained equations technique. Only the first imputation
will be used in analyses. The remaining four will be reserved
for sensitivity analysis of the main findings.
Description of outcomes and effect modifiers
We selected three clinical important outcomes of interest
from a larger list of outcomes used in the analysis by Briel
et al. [5]:
In-hospital mortality at 60 days post randomization
(outcome 1a) constitutes the primary efficacy outcome
of interest. We will also consider in-hospital mortality as
a time-to-event variable (outcome 1b) because we are
additionally interested in the timing of mortality events
in the randomized groups. Due to the differential follow-
up across RCTs beyond day 60 and the fact that the inter-
vention effects happen mainly within the first month, we
will censor all surviving patients in the time to event
analysis at day 60 as done in the original IPD meta-analysis.
Time to unassisted breathing (outcome 2), which is
defined as time from randomization until breathing without
mechanical support within the first 28 days is the secondary
efficacy outcome of interest. Due to differential follow-up
across RCTs for this outcome beyond day 28 and the fact
that the intervention effect is supposed to happen beforeday 28, we will censor patients at day 28 as done in the
original IPD meta-analysis. Patients who die before achiev-
ing unassisted breathing within the first 28 days will be
censored at the day of death. With this procedure we
circumvent the competing risk issue in the analysis of this
outcome. We are aware of the fact that for prognostic
questions, which will not be part of this analysis, cumulative
incidence functions would be preferred.
Pneumothorax requiring chest tube drainage in first
28 days after randomization (outcome 3, binary variable)
is the main safety outcome, because it captures the main
potential adverse event directly associated with higher
PEEP (experimental intervention). Again, the reason for
choosing a 28-day period is that the follow-up for this
outcome is different across included trials beyond day
28 and the intervention effect is supposed to happen
within the first 28 days. In the present protocol we will
not analyze outcome 3 (main safety outcome) because of
competing risks with mortality [15]. In the planned clin-
ical report of this work we will refer to the results of the
original IPD meta-analysis with respect to outcome 3,
because the MFPI methodology has still to be adapted for
a competing risk framework. We will deal with competing
risks in an addition to this protocol. For the specified
efficacy outcomes (outcomes 1a/b and 2) we anticipate no
competing risk problems when using cause-specific Cox
models.
The following four continuous potential effect modifiers
were all pre-specified by Briel et al. [5]:
Body Mass Index (BMI) at baseline
The BMI is calculated by the ratio of mass in Kg/(Height
in m)2. There are no data that suggest a certain direction
of the treatment effect modification, but Briel et al.
hypothesized less benefit of higher PEEP in patients with
higher BMI [5].
Respiratory compliance (RC) at baseline
The RC is estimated by the ratio of:
Tidal volume= Inspiratory plateau pressure−PEEPð Þ
A lower RC would reflect more severe lung injury.
Briel et al. hypothesized that patients with lower RC have
more recruitable lung units and would therefore benefit
from higher levels of PEEP. In addition, one could argue
that in patients suffering from most severe ARDS, which
is commonly associated with very low RC, higher PEEP
might no longer provide any benefit.
PaO2/FiO2 ratio at baseline
A low PaO2/FiO2 reflects impaired blood oxygenation
and, therefore, more severe lung injury. Similar to RC,
Briel et al. hypothesized that patients with a lower PaO2/
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interesting to see how the widely accepted ARDS defining
cut-off at 200 mmHg, is reflected in this analysis using
the MFPI approach. Using this cut-off, a significant
interaction was found by Briel et al. [5,6].
Oxygenation Index at baseline
The oxygenation index (OI) defined as:
mean airway pressure  100= PaO2=FiO2ratio½ 
includes the mean airway pressure and can be regarded
as the more reliable marker regarding blood oxygenation
compared to the PaO2/FiO2 ratio alone. The higher the
OI, the more severe the lung injury; therefore, Briel et al.
hypothesized that patients with a higher OI benefit more
from higher PEEP levels [5].
Further candidates (for example, age and sex) may be
additionally investigated for interaction. Of note, irrespect-
ive of the results, all investigations will be included in
a summary table similar to the REMARK profile for
prognostic studies [16].
Discussion
The ICEM study is the first example that combines esti-
mation of treatment effect functions by using MFPI with
a new approach for a meta-analysis of functions for a
clinically relevant issue. The approach requires IPD data,
which are available from an earlier meta-analysis project.
The present article is an extended version of the registered
protocol, and shows in an exemplary way how to better
use the information from continuous variables if individ-
ual patient data from several RCTs are available. In similar
projects, it should be obvious how to adapt the relevant
steps for a meta-analysis of treatment effect functions.
Besides the new application of the MFPI approach in
meta-analysis, the available dataset from three RCTs also
offers a unique opportunity to identify potential clinically
important interaction effects. All these interaction ana-
lyses are exploratory in nature; however, they use the full
information for a potential treatment modifier and may
help in clinical decision-making. We hope that this project
will also foster future research using the MFPI approach
to improve interaction analyses of continuous predictors
in RCTs and in meta-analyses, provided IPD are available.
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